Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

RELX PLC is a global provider of information-based analytics and decision tools for professional and business customers. The Company serves customers in approximately 180 countries and has offices in about 40 countries. It operates in four market segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. Its Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms. Its Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science, advance healthcare and improve performance. Its Legal segment provides legal, regulatory and business information and analytics that helps customers increase their productivity and decision-making. Its Exhibitions segment combines face-to-face with data and digital tools to help customers learn about markets source products and complete transactions.

  • Revenue in USD (TTM)9.56bn
  • Net income in USD1.92bn
  • Incorporated1903
  • Employees33.50k
  • Location
    Relx PLCGrand Buildings, 1-3 StrandLONDON WC2N 5JRUnited KingdomGBR
  • Phone+44 207 166 5660
  • Fax+44 207 166 5799
  • Websitehttps://www.relx.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.